You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 5,747,340


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,747,340
Title: Targeted gene expression using preproendothelin-1 promoters
Abstract:This invention provides a vector for expression of a nucleic acid cassette in bronchial epithelial and vascular endothelial cells comprising a segment of the 5\'-flanking region of the preproendothelin-1 gene, upstream from the transcription start site, the first exon of the preproendothelin-1 gene, and a nucleic acid cassette, wherein the nucleic acid cassette is located within the first exon, in sequential and positional relationship for expression of the nucleic acid cassette.
Inventor(s): Harats; Dror (Ramat-Gan, IL), Kurihara; Hiroki (Toyko, JP), Belloni; Paula Nanette (Moss Beach, CA), Sigal; Charles Elliott (San Francisco, CA)
Assignee: Syntex (U.S.A.) Inc. (Palo Alto, CA)
Application Number:08/395,742
Patent Claims:1. A vector for expression of a nucleic acid casette comprising a murine preproendothelin-1 gene 5'-flanking segment, the first exon of the preproendothelin-1 gene, and a nucleic acid cassette, wherein the nucleic acid cassette is located within the first exon, in sequential and positional relationship for expression of the nucleic acid cassette.

2. A vector of claim 1 further comprising the first intron of the preproendothelin-1 gene, said intron located downstream from the first exon.

3. A vector of claim 2 comprising about 0.8 kb of the first intron.

4. A vector of claim 3 wherein the nucleic acid cassette is positioned between the noncoding and coding regions of said exon, in sequential and positional relationship for expression of the nucleic acid cassette.

5. A vector of claim 1 wherein the segment of the 5'-flanking region comprises about the first 0.45 kb upstream from the transcription start site.

6. A vector of claim 1 wherein the segment of the 5'-flanking region comprises about the first 1.4 kb upstream from the transcription start site.

7. A vector of claim 1 wherein the segment of the 5'-flanking region comprises about the first 5.9 kb upstream from the transcription start site.

8. A vector of claim 1 wherein the segment of the 5'-flanking region comprises about the first 9.1 kb upstream from the transcription start site.

9. A vector of claim 3 comprising 0.45 kb of the 5'-flanking region, the first exon, and about 0.8 kb of the first intron of the preproendothelin-1 gene.

10. A vector of claim 3 comprising 1.4 kb of the 5'-flanking region, the first exon, and about 0.8 kb of the first intron of the preproendothelin-1 gene.

11. A vector of claim 3 comprising 5.9 kb of the 5'-flanking region, the first exon, and about 0.8 kb of the first intron of the preproendothelin-1 gene.

12. A vector of claim 1 wherein the cassette comprises a nucleic acid sequence encoding a protein, a polypeptide, a ribozyme, or an antisense RNA.

13. The isolated genomic murine preproendothelin-1 5'-flanking region.

14. A plasmid comprising the 5'-flanking region of claim 13.

15. A method for expressing a gene of interest in vascular endothelial or bronchial epithelial cells which method comprises transfecting the cells with a vector of claim 1.

Details for Patent 5,747,340

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2015-05-05
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2015-05-05
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2015-05-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.